NO_LONGER_AVAILABLENCT00852345
Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kaiser Permanente
- Principal Investigator
- Arnold M Henson, MDKaiser Permanente
- Intervention
- clofazamine(drug)
- Eligibility
- 18 years · All sexes
Study locations (1)
- Kaiser Permanente, Irvine, California, United States
Collaborators
Health Resources and Services Administration (HRSA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00852345 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia
- RECRUITINGNANCT06222372Novel Interventions and Diagnostic Tests for LeprosyAnnemieke Geluk